S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(0.27%) $78.32
Gas
(0.33%) $2.15
Gold
(0.49%) $2 319.80
Silver
(1.75%) $27.16
Platinum
(-0.39%) $961.55
USD/EUR
(0.01%) $0.929
USD/NOK
(-0.09%) $10.86
USD/GBP
(-0.02%) $0.797
USD/RUB
(0.00%) $91.45

Echtzeitaktualisierungen für Vectura Group PLC [VEC.L]

Börse: LSE Industrie: Pharmaceuticals, Biotechnology & Life Sciences
Zuletzt aktualisiert1 Jan 1970 @ 01:00

0.00% £ 164.80

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 01:00):

Vectura Group Plc engages in the provision of pharmaceutical development. The company is headquartered in Chippenham, Wiltshire and currently employs 453 full-time employees...

Stats
Tagesvolumen 203 762
Durchschnittsvolumen 8.30M
Marktkapitalisierung 0.00
EPS £-0.00834 ( 2019-06-29 )
Last Dividend £19.00 ( 2021-06-01 )
Next Dividend £0 ( N/A )
P/E 0.0800
ATR14 £0 (0.00%)

Vectura Group PLC Korrelation

10 Am meisten positiv korreliert
10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Vectura Group PLC Finanzdaten

Annual 2020
Umsatz: £190.60M
Bruttogewinn: £101.40M (53.20 %)
EPS: £0.188
FY 2020
Umsatz: £190.60M
Bruttogewinn: £101.40M (53.20 %)
EPS: £0.188
FY 2019
Umsatz: £178.30M
Bruttogewinn: £95.30M (53.45 %)
EPS: £-0.0340
FY 2018
Umsatz: £160.50M
Bruttogewinn: £98.90M (61.62 %)
EPS: £-0.143

Financial Reports:

No articles found.

Vectura Group PLC Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)

Vectura Group PLC Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.35 - Potential for dividend initiation, but uncertain (13.08%)
Information
First Dividend £6.50 2019-10-14
Last Dividend £19.00 2021-06-01
Next Dividend £0 N/A
Payout Date 2021-06-11
Next Payout Date N/A
# dividends 2 --
Total Paid Out £25.50 --
Avg. Dividend % Per Year 0.00% --
Score 2.69 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 4.35
Div. Directional Score 8.24 --
Next Divdend (Est)
(2025-10-01)
£0 Estimate 0.00 %
Dividend Stability
0.02 Very Bad
Dividend Score
2.69
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
2019 £0 0.00%
2020 £0 0.00%
2021 £0 0.00%
2022 £0 0.00%
2023 £0 0.00%
2024 £0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
TYMN.L Dividend Knight 2023-08-03 Annually 29 2.69%
MGCI.L Dividend King 2023-08-03 Quarterly 6 3.54%
CTEC.L Dividend Knight 2023-08-17 Semi-Annually 8 1.46%
SCP.L Dividend Knight 2023-07-13 Semi-Annually 31 1.83%
HTG.L Dividend King 2023-10-05 Semi-Annually 32 1.82%
BCPT.L Dividend King 2023-09-14 Monthly 20 2.80%
WKP.L Dividend Junior 2023-07-06 Annually 31 2.53%
NAIT.L Dividend Knight 2023-07-20 Quarterly 53 2.33%
ECK.L Dividend Knight 2023-09-21 Annually 14 0.93%
SOM.L Dividend King 2023-09-21 Semi-Annually 18 5.37%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.6421.50010.0010.00[0 - 0.5]
returnOnAssetsTTM0.1841.2003.874.65[0 - 0.3]
returnOnEquityTTM0.2541.5008.2910.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.590.80010.008.00[1 - 3]
quickRatioTTM0.9230.8009.287.42[0.8 - 2.5]
cashRatioTTM0.9231.5005.998.98[0.2 - 2]
debtRatioTTM0.00631-1.5009.89-10.00[0 - 0.6]
interestCoverageTTM1 314.001.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM0.03802.009.9910.00[0 - 30]
freeCashFlowPerShareTTM0.01812.009.9910.00[0 - 20]
debtEquityRatioTTM0.00771-1.5009.97-10.00[0 - 2.5]
grossProfitMarginTTM0.5321.0004.474.47[0.2 - 0.8]
operatingProfitMarginTTM0.6891.00010.0010.00[0.1 - 0.6]
cashFlowToDebtRatioTTM5.901.00010.0010.00[0.2 - 2]
assetTurnoverTTM0.2860.800-1.425-1.140[0.5 - 2]
Total Score12.14

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM8.781.0009.210[1 - 100]
returnOnEquityTTM0.2542.508.9010.00[0.1 - 1.5]
freeCashFlowPerShareTTM0.01812.009.9910.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.03802.009.9910.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1301.0009.250[0.1 - 0.5]
Total Score4.35

Vectura Group PLC

Vectura Group Plc engages in the provision of pharmaceutical development. The company is headquartered in Chippenham, Wiltshire and currently employs 453 full-time employees. The firm's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) - ICS-LABA; ADVATE (Global) - Antihaemophilic Factor (Recombinant); Adept (Global) - Icodextrin; Anoro Ellipta (Global) - LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) - ICS-LABA, and Incruse Ellipta (Global) - LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.